NURECA
Back to Cashflow Statement
|
NURECA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-20 Cr | ₹-0.17 Cr | ₹-1.30 Cr | ₹-1.51 Cr | ₹-7.30 Cr |
What is the latest Cash Flow from Financing Activities ratio of NURECA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-20 Cr |
| Mar2025 | ₹-0.17 Cr |
| Mar2024 | ₹-1.30 Cr |
| Mar2023 | ₹-1.51 Cr |
| Mar2022 | ₹-7.30 Cr |
How is Cash Flow from Financing Activities of NURECA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-20 Cr | Negative | |
| Mar2025 | ₹-0.17 Cr | Negative | |
| Mar2024 | ₹-1.30 Cr | Negative | |
| Mar2023 | ₹-1.51 Cr | Negative | |
| Mar2022 | ₹-7.30 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NURECA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NURECA | ₹316.0 Cr | -3.9% | 5% | 38.3% | Stock Analytics | |
| LENSKART SOLUTIONS | ₹117,881.0 Cr | -2% | -2.6% | NA | Stock Analytics | |
| POLY MEDICURE | ₹16,069.8 Cr | -2% | -8.4% | -16.2% | Stock Analytics | |
| 3B BLACKBIO DX | ₹1,352.4 Cr | -3.4% | 8.1% | 7.6% | Stock Analytics | |
| LAXMI DENTAL | ₹1,074.7 Cr | 2.6% | -1.9% | -41.7% | Stock Analytics | |
| PREVEST DENPRO | ₹459.0 Cr | 0.5% | -1.4% | -30% | Stock Analytics | |
NURECA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NURECA | -3.9% |
5% |
38.3% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses